Primary duodenal T/histiocyte-rich large B-cell lymphoma complicated with obstructive jaundice: A case report and review of literature
Primary duodenal T/HRBCL is an extremely rare and highly aggressive malignancy. The initial treatment strategies should be based on the original site of the tumor, the disease stage, and the patient's physical condition. Chemotherapy-based comprehensive treatment is still the main treatment method for primary gastrointestinal T/HRBCL.
Authors
- A-Niu Liu
- Xingyu Chen (ORCID: https://orcid.org/0009-0009-9673-4124)
- Yi‐Hua Chen (ORCID: https://orcid.org/0000-0002-4390-1090)
- Shanshan Wu (ORCID: https://orcid.org/0009-0007-9695-8051)
- Shumei Zheng
- Jiayi Yang
- Se-Niu Ji Zhi
Institutions
- North Sichuan Medical University (CN)
- Chengdu Military General Hospital (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2024-12-27
- DOI
- https://doi.org/10.4240/wjgs.v17.i1.99758
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.85